FR2890977A1 - Procede d'obtention de cellules musculaires lisses humaines et leurs applications - Google Patents

Procede d'obtention de cellules musculaires lisses humaines et leurs applications Download PDF

Info

Publication number
FR2890977A1
FR2890977A1 FR0509557A FR0509557A FR2890977A1 FR 2890977 A1 FR2890977 A1 FR 2890977A1 FR 0509557 A FR0509557 A FR 0509557A FR 0509557 A FR0509557 A FR 0509557A FR 2890977 A1 FR2890977 A1 FR 2890977A1
Authority
FR
France
Prior art keywords
cells
medium
human
hcms
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR0509557A
Other languages
English (en)
French (fr)
Inventor
Ricousse Sophie Le
Marie Noelle Lacassagne
Jean Pierre Marolleau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
IVS Institut des Vaisseaux et du Sang
Original Assignee
Assistance Publique Hopitaux de Paris APHP
IVS Institut des Vaisseaux et du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP, IVS Institut des Vaisseaux et du Sang filed Critical Assistance Publique Hopitaux de Paris APHP
Priority to FR0509557A priority Critical patent/FR2890977A1/fr
Priority to PCT/FR2006/002144 priority patent/WO2007034069A1/fr
Priority to CN2006800428874A priority patent/CN101310013B/zh
Priority to JP2008531733A priority patent/JP2009508511A/ja
Priority to CA002622916A priority patent/CA2622916A1/fr
Priority to US12/067,218 priority patent/US20090269310A1/en
Priority to AT06808166T priority patent/ATE531791T1/de
Priority to EP06808166A priority patent/EP1934333B9/fr
Priority to AU2006293814A priority patent/AU2006293814B2/en
Publication of FR2890977A1 publication Critical patent/FR2890977A1/fr
Priority to IL190289A priority patent/IL190289A0/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0661—Smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1323—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from skeletal muscle cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0509557A 2005-09-19 2005-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications Withdrawn FR2890977A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR0509557A FR2890977A1 (fr) 2005-09-19 2005-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications
US12/067,218 US20090269310A1 (en) 2005-09-19 2006-09-19 Method for obtaining human smooth muscular cells and uses thereof
CN2006800428874A CN101310013B (zh) 2005-09-19 2006-09-19 人平滑肌细胞的获得方法及其用途
JP2008531733A JP2009508511A (ja) 2005-09-19 2006-09-19 ヒト平滑筋細胞の獲得方法およびヒト平滑筋細胞の適用
CA002622916A CA2622916A1 (fr) 2005-09-19 2006-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications
PCT/FR2006/002144 WO2007034069A1 (fr) 2005-09-19 2006-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications
AT06808166T ATE531791T1 (de) 2005-09-19 2006-09-19 Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon
EP06808166A EP1934333B9 (fr) 2005-09-19 2006-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications
AU2006293814A AU2006293814B2 (en) 2005-09-19 2006-09-19 Method for obtaining human smooth muscular cells and uses thereof
IL190289A IL190289A0 (en) 2005-09-19 2008-03-19 Method for obtaining human smooth muscular cells and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509557A FR2890977A1 (fr) 2005-09-19 2005-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications

Publications (1)

Publication Number Publication Date
FR2890977A1 true FR2890977A1 (fr) 2007-03-23

Family

ID=36587333

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0509557A Withdrawn FR2890977A1 (fr) 2005-09-19 2005-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications

Country Status (10)

Country Link
US (1) US20090269310A1 (enExample)
EP (1) EP1934333B9 (enExample)
JP (1) JP2009508511A (enExample)
CN (1) CN101310013B (enExample)
AT (1) ATE531791T1 (enExample)
AU (1) AU2006293814B2 (enExample)
CA (1) CA2622916A1 (enExample)
FR (1) FR2890977A1 (enExample)
IL (1) IL190289A0 (enExample)
WO (1) WO2007034069A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909559A1 (fr) * 2006-12-06 2008-06-13 Inst Vaisseaux Et Du Sang Ass Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101724639B1 (ko) * 2008-11-04 2017-04-07 리젠메드 (케이만) 엘티디. 세포-지지체 구조물
HRP20230474T1 (hr) * 2017-12-14 2023-07-21 Innovacell Ag Postupci za dobivanje stanica izvedenih iz mišića
CN112119155A (zh) * 2018-05-08 2020-12-22 苏黎士大学 用于无异种产生hMPC群的方法
EP4397752A3 (en) * 2019-03-22 2024-10-02 Innovacell GmbH Methods for obtaining induced smooth muscle cells
CN120418415A (zh) * 2022-12-28 2025-08-01 因特斯迪姆株式会社 细胞组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001094555A1 (fr) * 2000-06-07 2001-12-13 Assistance Publique - Hopitaux De Paris Procede d'obtention de populations cellulaires caracterisees d'origine musculaire et utilisations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040247575A1 (en) * 2003-06-03 2004-12-09 Caplice Noel M. Smooth muscle progenitor cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001094555A1 (fr) * 2000-06-07 2001-12-13 Assistance Publique - Hopitaux De Paris Procede d'obtention de populations cellulaires caracterisees d'origine musculaire et utilisations

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HUARD J ET AL: "Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction", GENE THERAPY, MACMILLAN PRESS LTD., BASINGSTOKE, GB, vol. 9, no. 23, December 2002 (2002-12-01), pages 1617 - 1626, XP002370482, ISSN: 0969-7128 *
HWANG JI HYE ET AL: "Isolation of muscle derived stem cells from rat and its smooth muscle differentiation [corrected].", MOLECULES AND CELLS, vol. 17, no. 1, 29 February 2004 (2004-02-29), pages 57 - 61, XP002387435, ISSN: 1016-8478 *
LE RICOUSSE-ROUSSANNE SOPHIE ET AL: "Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature.", CARDIOVASCULAR RESEARCH, vol. 62, no. 1, 1 April 2004 (2004-04-01), pages 176 - 184, XP002387433, ISSN: 0008-6363 *
QU-PETERSEN Z ET AL: "Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration", JOURNAL OF CELL BIOLOGY, vol. 157, no. 5, 27 May 2002 (2002-05-27), pages 851 - 864, XP002302343, ISSN: 0021-9525 *
SIMPER DAVID ET AL: "Smooth muscle progenitor cells in human blood.", CIRCULATION, vol. 106, no. 10, 3 September 2002 (2002-09-03), pages 1199 - 1204, XP002387434, ISSN: 1524-4539 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909559A1 (fr) * 2006-12-06 2008-06-13 Inst Vaisseaux Et Du Sang Ass Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
WO2008081116A3 (fr) * 2006-12-06 2008-09-12 Inst Vaisseaux Et Du Sang Préparations cellulaires pour une utilisation comme agent stimulant la revascularisation

Also Published As

Publication number Publication date
AU2006293814B2 (en) 2011-09-29
CN101310013B (zh) 2011-09-07
US20090269310A1 (en) 2009-10-29
EP1934333A1 (fr) 2008-06-25
CA2622916A1 (fr) 2007-03-29
IL190289A0 (en) 2011-08-01
ATE531791T1 (de) 2011-11-15
CN101310013A (zh) 2008-11-19
EP1934333B1 (fr) 2011-11-02
JP2009508511A (ja) 2009-03-05
AU2006293814A1 (en) 2007-03-29
EP1934333B9 (fr) 2012-05-02
WO2007034069A1 (fr) 2007-03-29

Similar Documents

Publication Publication Date Title
Alviano et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro
Mimeault et al. Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies
Fukuda et al. Stem cells as a source of regenerative cardiomyocytes
Gnecchi et al. Mesenchymal stem cell therapy for heart disease
Silvestre et al. Postischemic revascularization: from cellular and molecular mechanisms to clinical applications
EP1349919B1 (fr) Cellules du tissu adipeux extramedullaire et leurs applications dans la reconstitution du tissu cardiaque
Drela et al. Endothelial progenitor cells in diabetic foot syndrome
EP1663263B1 (fr) Utilisation de cellules issues du tissu adipeux pour induire la formation d'un reseau vasculaire fonctionnel.
JP2013510582A (ja) 間葉幹細胞の球状集合体
WO2007085745A1 (fr) Procede de culture de cellules issues du tissu adipeux et leurs applications
Chen et al. Danhong injection enhances the therapeutic efficacy of mesenchymal stem cells in myocardial infarction by promoting angiogenesis
Lee et al. Remote transplantation of human adipose-derived stem cells induces regression of cardiac hypertrophy by regulating the macrophage polarization in spontaneously hypertensive rats
EP3174972A1 (fr) Procédé de production in vitro de progéniteurs adipocytaires et d'adipocytes
EP1934333B1 (fr) Procede d'obtention de cellules musculaires lisses humaines et leurs applications
EP3277297A1 (en) Methods and compositions for stimulation of cell proliferation and provision of biologically active mixtures of fgf2 isoforms
Lin et al. Intravenous transplantation of human hair follicle-derived mesenchymal stem cells ameliorates trabecular bone loss in osteoporotic mice
Xinyun et al. Effects of cardiotrophin-1 on differentiation and maturation of rat bone marrow mesenchymal stem cells induced with 5-azacytidine in vitro
Norol et al. GFP-transduced CD34+ and Lin− CD34− hematopoietic stem cells did not adopt a cardiac phenotype in a nonhuman primate model of myocardial infarct
KR102007872B1 (ko) 줄기세포를 멜라토닌 처리 하여 증식 촉진 또는 생존율을 증가시키는 방법
JP2009508511A5 (enExample)
Noort et al. Stem cells from in-or outside of the heart: isolation, characterization, and potential for myocardial tissue regeneration
Avogaro et al. Stem cell therapy in diabetes
Fazel Cardiac repair and not regeneration after myocardial infarction: the role and therapeutic utility of the c-kitSCF pathway.
Castaldi Pharmacological activation and reprogramming of muscle cells to acquire an earlier, pluripotent, circulating" stem-like" behaviour, suitable for therapeutical applications
Shams et al. Research Article Mesenchymal Stem Cells Pretreated with HGF and FGF4 Can Reduce Liver Fibrosis in Mice

Legal Events

Date Code Title Description
AU Other action affecting the ownership or exploitation of an industrial property right
ST Notification of lapse

Effective date: 20130531